Rapidly progressive DM-/CADM-ILD with the anti-MDA5 antibody is the most intractable condition and requires immediate combined immunosuppressive therapy with GCs, CNIs, and IVCY. The gene discussed is IFIH1; the disease is interstitial lung disease.